Afegostat
- Generic Name
- Afegostat
- Drug Type
- Small Molecule
- Chemical Formula
- C6H13NO3
- CAS Number
- 169105-89-9
- Unique Ingredient Identifier
- G23AP190YS
A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101
- First Posted Date
- 2009-04-03
- Last Posted Date
- 2010-08-19
- Lead Sponsor
- Amicus Therapeutics
- Target Recruit Count
- 1
- Registration Number
- NCT00875160
- Locations
- 🇺🇸
Comprehensive Phase One, Miramar, Florida, United States
🇬🇧Guy's Drug Research Unit, London, United Kingdom
A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients
Phase 2
Completed
- Conditions
- Gaucher DiseaseType 1 Gaucher DiseaseGaucher Disease, Type 1
- Interventions
- First Posted Date
- 2008-12-23
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Amicus Therapeutics
- Target Recruit Count
- 8
- Registration Number
- NCT00813865
A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease
Phase 2
Completed
- Conditions
- Gaucher DiseaseType 1 Gaucher DiseaseGaucher Disease, Type 1
- Interventions
- First Posted Date
- 2007-03-13
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Amicus Therapeutics
- Target Recruit Count
- 19
- Registration Number
- NCT00446550
A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy
Phase 2
Completed
- Conditions
- Gaucher Disease, Type 1Type 1 Gaucher DiseaseGaucher Disease
- Interventions
- First Posted Date
- 2007-02-09
- Last Posted Date
- 2018-09-25
- Lead Sponsor
- Amicus Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT00433147
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath